Stephanie Tirone
Acute Care · Glendale, AZNPI 1881298826
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.7%), other and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Angiodynamics, Inc. at 43.7% of the total. Reporting peaked in 2022 at $7,289 and has fallen 96.2% since, to $279 in 2024. Among acute care clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $60.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$5K
- Medtronic$3K
- Amgen$541
- Penumbra, Inc.$428
- Boston Scientific$421
- Merck$327
- plus $2K from 20 others
What the payments were for
- Travel & lodging$9019%
- Food & beverage$5,00548%
- Education$9799%
- Other$3,60034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $4,579 |
| Medtronic | 50 | $2,655 |
| Amgen | 20 | $541 |
| Penumbra, Inc. | 3 | $428 |
| Boston Scientific | 19 | $421 |
| Merck | 17 | $327 |
| Novo Nordisk | 11 | $313 |
| AstraZeneca | 8 | $227 |
| Impulse Dynamics (USA) Inc. | 5 | $215 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $111 |
| Amarin Pharma, Inc. | 7 | $102 |
| Boehringer Ingelheim | 5 | $100 |
| EMD Serono, Inc. | 1 | $79 |
| Novartis | 3 | $74 |
| Johnson & Johnson | 3 | $48 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $40 |
| Lexicon Pharmaceuticals, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Cordis US CORP. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Pfizer | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,485 in reported general payments places this provider in the 95th percentile of 482 acute care providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 16 | $9,990 |
| Ezetimibe | 20 | $1,057 |
| Rosuvastatin Calcium | 24 | $428 |
| Metoprolol Succinate | 23 | $327 |
| Atorvastatin Calcium | 21 | $243 |
| ClopidogrelClopidogrel Bisulfate | 14 | $201 |
| Lisinopril | 20 | $96 |
Paid to pharmacies, not to this prescriber.
Other acute care in Glendale
- Nichole LeeGlendale$9K
- Jabez BarajasGlendale$9K
- Dana SochackiGlendale$8K
- Robin McLinnGlendale$5K
- Melissa LockettGlendale$5K
- Nicole CiffoneTucson$162K
- Kim KrmpoticPhoenix$79K
- Stephanie WilsonScottsdale$37K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.